Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
MRK
MRK
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MRK News
EUROPEAN COMMISSION GIVES GREEN LIGHT TO MERCK'S ENFLONSIA™ (CLESROVIMAB) FOR INFANT RSV LOWER RESPIRATORY TRACT DISEASE PREVENTION IN FIRST RSV SEASON
2d ago
moomoo
Health Care Stocks Rise 1.4% on NYSE
2d ago
Yahoo Finance
Analysis of Dividend Stocks in the Pharmaceutical Industry
2d ago
Fool
Merck Shares Rebound After Acquisition of Terns Pharmaceuticals
2d ago
seekingalpha
Trump Nominates New CDC Director Amid Turmoil
3d ago
CNBC
Analysis and Recommendations on Stocks Near Market Highs
5d ago
Yahoo Finance
Rapid Growth of GLP-1 Drug Market
6d ago
NASDAQ.COM
Bristol Myers Squibb: A New Value Investment Choice
6d ago
Fool
Investment Analysis of Bristol Myers Squibb
6d ago
NASDAQ.COM
European Pharma Industry Faces Competitive Pressures
Apr 11 2026
CNBC
Europe's Pharmaceutical Market Share Declines Amid U.S. and China Competition
Apr 11 2026
Newsfilter
Merck Stock Shows Potential Breakout Patterns
Apr 10 2026
CNBC
Revolution Medicines Nears Release of Pancreatic Cancer Drug Trial Results
Apr 10 2026
CNBC
Chip Stocks Surge as Investors Favor Semiconductors Over Software
Apr 10 2026
CNBC
FDA Approves 46 Novel Drugs in 2025, Addressing Various Diseases
Apr 10 2026
NASDAQ.COM
CDC Vaccine Advisory Committee Receives New Operating Rules
Apr 10 2026
seekingalpha
Show More News
